Search Results - "Pittion, Sophie"

Clinical and radiological activity of secondary progressive multiple sclerosis in a population‐based cohort by Mathey, Guillaume, Ancel, Thomas, Garot, Teresa, Soudant, Marc, Pittion‐Vouyovitch, Sophie, Guillemin, Francis, Debouverie, Marc, Epstein, Jonathan

“…Background and purpose Patients with secondary progressive multiple sclerosis (SP MS) and clinical and/or radiological activity could be the more likely to…”
Get full text

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability by Zéphir, Hélène, Bernard-Valnet, Raphaël, Lebrun, Christine, Outteryck, Olivier, Audoin, Bertrand, Bourre, Bertrand, Pittion, Sophie, Wiertlewski, Sandrine, Ouallet, Jean Christophe, Neau, Jean-Philippe, Ciron, Jonathan, Clavelou, Pierre, Marignier, Romain, Brassat, David

“…Neuromyelitis optica (NMO) is a life-threatening disease without any validated treatment strategy. Recent retrospective studies suggested the efficacy of B…”
Get full text

SOD1-related ALS with anticipation in a large family from Martinique by Giguet-Valard, Anna-Gaelle, Bellance, Rémi, Jeannin, Séverine, Duclos, Sophie, Olive, Pascale, Allard-Saint-Albin, Oriane, Cazeneuve, Cécile, Clot, Fabienne, Sophie, Pittion-Vouyovitch, Barnetche, Thomas, Smith-Ravin, Juliette, Goizet, Cyril

“…Amyotrophic Lateral Sclerosis (ALS) is a rare neurological disorder that causes degeneration of upper and lower motor neurons and their axons. ALS is mostly…”
Get full text

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis by Brochet, Bruno, Deloire, Mathilde S A, Perez, Paul, Loock, Timothé, Baschet, Louise, Debouverie, Marc, Pittion, Sophie, Ouallet, Jean-Christophe, Clavelou, Pierre, de Sèze, Jérôme, Collongues, Nicolas, Vermersch, Patrick, Zéphir, Hélène, Castelnovo, Giovanni, Labauge, Pierre, Lebrun, Christine, Cohen, Mikael, Ruet, Aurélie

“…Therapeutic options are limited in secondary progressive multiple sclerosis (SPMS). Open-label studies suggested efficacy of monthly IV cyclophosphamide (CPM)…”
Get full text

Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system ? by Amador, Maria del Mar, MD, Vandenberghe, Nadia, MD, Berhoune, Nawel, MD, Camdessanché, Jean-Philippe, MD, PhD, Gronier, Sophie, MD, Delmont, Emilien, MD, PhD, Desnuelle, Claude, MD, PhD, Cintas, Pascal, MD, Pittion, Sophie, MD, Louis, Sarah, MD, Demeret, Sophie, MD, Lenglet, Timothée, MD, Meininger, Vincent, MD, PhD, Salachas, François, MD, Pradat, Pierre-François, MD, PhD, Bruneteau, Gaëlle, MD, PhD

“…Highlights • We describe the largest series of co-occurence of ALS and myasthenia gravis. • This association is rare and requires strict diagnostic criteria. •…”
Get full text

Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study by Nardin, Clotilde, Latarche, Clotilde, Soudant, Marc, Dahan, Camille, Michaud, Maud, Pittion-Vouyovitch, Sophie, Guillemin, Francis, Debouverie, Marc, Mathey, Guillaume

“…The incidence of multiple sclerosis (MS) changes from generation to generation in ethnically different immigrants compared with native-born people. We aimed to…”
Get full text

Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course by Mathey, Guillaume, Pisché, Guillaume, Soudant, Marc, Pittion-Vouyovitch, Sophie, Guillemin, Francis, Debouverie, Marc, Epstein, Jonathan

“…Objective To describe the course of disability in patients with benign multiple sclerosis—i.e., with an expanded disability status scale score < 3 10 years…”
Get full text

Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome by Thouvenot, Eric, Hinsinger, Geoffrey, Demattei, Christophe, Uygunoglu, Ugur, Castelnovo, Giovanni, Pittion-Vouyovitch, Sophie, Okuda, Darin, Kantarci, Orhun, Pelletier, Daniel, Lehmann, Sylvain, Marin, Philippe, Siva, Aksel, Lebrun, Christine

“…Background: Younger age, male sex and presence of spinal cord lesion(s) increase the risk of conversion from radiologically isolated syndrome (RIS) to…”
Get full text

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition by Huin, Vincent, Blum, David, Delforge, Violette, Cailliau, Emeline, Djeziri, Sofia, Dujardin, Kathy, Genet, Alexandre, Viard, Romain, Attarian, Shahram, Bruneteau, Gaelle, Cassereau, Julien, Genestet, Steeve, Kaminsky, Anne-Laure, Soriani, Marie-Hélène, Lefilliatre, Mathilde, Couratier, Philippe, Pittion-Vouyovitch, Sophie, Esselin, Florence, De La Cruz, Elisa, Guy, Nathalie, Kolev, Ivan, Corcia, Philippe, Cintas, Pascal, Desnuelle, Claude, Buée, Luc, Danel-Brunaud, Véronique, Devos, David, Rolland, Anne-Sophie

“…Caffeine consumption outcomes on Amyotrophic Lateral Sclerosis (ALS) including progression, survival and cognition remain poorly defined and may depend on its…”
Get full text

Neurofilament-Light Chain Levels Are Predictive of On-going Disease Activity in Radiologically Isolated Syndrome (S37.003) by Thouvenot, Eric, Demattei, Christophe, Uygunoglu, Ugur, Pittion, Sophie, Castelnovo, Giovanni, de Terdonck, Luciel Du Trieu, Cohen, Mikael, Okuda, Darin, Kantarci, Orhun, Pelletier, Daniel, Marin, Philippe, Lehmann, Sylvain, Siva, Aksel, Frenay, Christine Lebrun

“…Abstract only…”
Get full text

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients by Ayrignac, Xavier, Carra-Dalliere, Clarisse, Menjot de Champfleur, Nicolas, Denier, Christian, Aubourg, Patrick, Bellesme, Celine, Castelnovo, Giovanni, Pelletier, Jean, Audoin, Bertrand, Kaphan, Elsa, de Seze, Jerome, Collongues, Nicolas, Blanc, Frederic, Chanson, Jean-Baptiste, Magnin, Eloi, Berger, Eric, Vukusic, Sandra, Durand-Dubief, Francoise, Camdessanche, Jean-Philippe, Cohen, Mickael, Lebrun-Frenay, Christine, Brassat, David, Clanet, Michel, Vermersch, Patrick, Zephir, Helene, Outteryck, Olivier, Wiertlewski, Sandrine, Laplaud, David-Axel, Ouallet, Jean-Christophe, Brochet, Bruno, Goizet, Cyril, Debouverie, Marc, Pittion, Sophie, Edan, Gilles, Deburghgraeve, Véronique, Le Page, Emmanuelle, Verny, Christophe, Amati-Bonneau, Patrizia, Bonneau, Dominique, Hannequin, Didier, Guyant-Maréchal, Lucie, Derache, Nathalie, Defer, Gilles Louis, Moreau, Thibault, Giroud, Maurice, Guennoc, Anne Marie, Clavelou, Pierre, Taithe, Frédérique, Mathis, Stephane, Neau, Jean-Philippe, Magy, Laurent, Devoize, Jean Louis, Bataillard, Marc, Masliah-Planchon, Julien, Dorboz, Imen, Tournier-Lasserve, Elisabeth, Levade, Thierry, Boespflug Tanguy, Odile, Labauge, Pierre

“…Inherited white matter diseases are rare and heterogeneous disorders usually encountered in infancy. Adult-onset forms are increasingly recognized. Our…”
Get full text

Cognitive impairment among different clinical courses of multiple sclerosis by Brissart, Helene, Morele, Elodie, Baumann, Cedric, Perf, Matthieu Le, Leininger, Matthieu, Taillemite, Laetitia, Dillier, Céline, Pittion, Sophie, Spitz, Elisabeth, Debouverie, Marc

“…Background: As of yet, no consensus has been reached regarding cognitive impairment profiles in multiple sclerosis (MS) patients based on the MS type and…”
Get full text

Double‐blind, randomized controlled trial of therapeutic plasma exchanges vs sham exchanges in moderate‐to‐severe relapses of multiple sclerosis by Brochet, Bruno, Deloire, Mathilde, Germain, Christine, Ouallet, Jean‐Christophe, Wittkop, Linda, Dulau, Cécile, Perez, Paul, Thevenot, Florian, De Sèze, Jérome, Zéphir, Hélène, Vermersch, Patrick, Pittion, Sophie, Debouverie, Marc, Laplaud, David‐Axel, Clavelou, Pierre, Ruet, Aurélie

“…Introduction No randomized controlled clinical trial of therapeutic plasma exchanges (TPE) has yet been performed for moderate‐to‐severe relapses of multiple…”
Get full text

Rituximab as First-Line Therapy in Neuromyelitis Optica: Efficiency and Tolerability (P5.258) by Bernard-Valnet, Raphael, Lebrun Frenay, Christine, Audoin, Bertrand, Bourre, Bertrand, Pittion, Sophie, Wiertlewski, Sandrine, Marignier, Romain, Ciron, Jonathan, Brochet, Bruno, Brassat, David, Zephir, Helene

“…Abstract only…”
Get full text

Results from a randomized double-blind crossover study comparing oral L-carnitine versus placebo and a subsequent physical rehabilitation program for the treatment of fatigue in multiple sclerosis (P1.125) by Ouallet, Jean-Christophe, Asselineau, Julien, Laplaud, David, Wiertlewski, Sandrine, Pittion, Sophie, Debouverie, Marc, Lebrun Frenay, Christine, Cohen, Mickael, Cabre, Philippe, Jeannin, Severine, Chene, Genevieve, Brassat, David, Saubusse, Aurore, Djigo, Dieynaba, Chateauraynaud, Jeremy, Brochet, Bruno

“…Abstract only…”
Get full text

Efficacy and safety of alemtuzumab in 113 patients with active relapsing-remitting MS: one-year follow-up in France (P5.347) by Ayrignac, Xavier, Collongues, Nicolas, De Seze, Jerome, Vermersch, Patrick, Biotti, Damien, BRASSAT, DAVID, Vukusic, Sandra, Durand-Dubief, Françoise, Edan, Gilles, Lepage, Emmanuelle, Deburghgraeve, Veronique, Maillart, Elisabeth, Papeix, Caroline, Alla, Philippe, Berger, Eric, Bourre, Bertrand, Casez, Olivier, Pittion, Sophie, Debouverie, Marc, Theaudin, Marie, Derache, Nathalie, Defer, Gilles, Gout, Olivier, Deschamps, Romain, Tourbah, Ayman, Zagnoli, Fabien, Ruet, Aurelie, Ouallet, Jean, Brochet, Bruno, Manchon, Eric, Moreau, Thibault, Fromont, Agnes, Clavelou, Pierre, Guennoc, Anne Marie, Camdessanche, Jean-Phillippe, Carpentier, Antoine, Coman, Irene Antoanela, Audoin, Bertrand, Pelletier, Jean, Magy, Laurent, Ciron, Jonathan, Wiertlevski, Sandrine, Laplaud, David, De Broucker, Thomas, Frenay, Christine Lebrun, Cohen, Mikael, Labauge, Pierre

“…Abstract only…”
Get full text

Clinical And Paraclinical Parameters Associated With Brain Atrophy In Newly Diagnosed MS Patients. (S13.004) by Bourre, Bertrand, Clerc, Christine, Blanc, Frederic, Noblet, Vincent, Kremer, Stephane, Lamy, Julien, Armspach, Jean-Paul, Brice, Baradi, Zephir, Helene, Outteryck, Olivier, Debouverie, Marc, Pittion, Sophie, Vermersch, Patrick, De Seze, Jerome

“…Abstract only…”
Get full text

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis by Manceau, Philippe, Latarche, Clotilde, Pittion, Sophie, Edan, Gilles, de Sèze, Jérôme, Massart, Catherine, Debouverie, Marc

“…The clinical impact of neutralizing antibodies against interferon-beta (NAb) is controversial. Their presence can lead to a decrease in interferon-beta (IFNβ)…”
Get full text

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study by Scherer, Louisa, Soudant, Marc, Pittion-Vouyovitch, Sophie, Debouverie, Marc, Guillemin, Francis, Epstein, Jonathan, Mathey, Guillaume

“…Background one of the most important therapeutic goals in relapse-onset multiple sclerosis is to preclude conversion to secondary progression. Our objective…”
Get full text

Identification des critères diagnostiques et des modalités de suivi de la sclérose en plaques secondairement progressive by Bourre, Bertrand, Ciron, Jonathan, Durand-Dubief, Françoise, Antoine, Gueguen, Pierre, Labauge, Ouallet, Jean-Christophe, Sophie, Pittion-Vouyovitch

“…Aujourd’hui, le diagnostic de sclérose en plaques (SEP) secondairement progressive (SP) est souvent tardif, rétrospectif et non reproductible en absence de…”
Get full text